Back to Agenda
New Approaches to International Collaboration Between Regulators (Part 2 of 2)
Session Chair(s)
Murray M. Lumpkin, DrMed, MD, MSc
Deputy Director, Integrated Development, Lead for Global Reg Systems Initiative
Bill and Melinda Gates Foundation, United States
Panelist
Learning Objective : Discuss the current challenges facing international regulators including how this impacts the pharmaceutical industry and patients; Describe emerging international initiatives.
Speaker(s)
Panelist
Emer Cooke, MBA, MSc
The European Medicines Agency, Netherlands
Executive Director, Chair, ICMRA
Panelist
John Skerritt, PhD
University of Melbourne, Australia
Enterprise Professor, Health Research Impact
Panelist
Aiping Zhang
China Food and Drug Administration (CFDA), China
Inspector General, Department of Drug and Cosmetics Supervision
Panelist
Lembit Rago, DrMed, MD, PhD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Secretary General
Panelist
Jaime César de Moura Oliveira, LLM
Agência Nacional De Vigilância Sanitária (ANVISA), Brazil
Director
Have an account?